Advances in Precision Medicine: Tailoring Individualized Therapies
The traditional bench-to-bedside pipeline involves using model systems and patient samples to provide insights into pathways deregulated in cancer. This discovery reveals new biomarkers and therapeutic targets, ultimately stratifying patients and informing cohort-based treatment options. Precision m...
Main Authors: | Kyle B. Matchett, Niamh Lynam-Lennon, R. William Watson, James A. L. Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/9/11/146 |
Similar Items
-
Zebrafish Avatars towards Personalized Medicine—A Comparative Review between Avatar Models
by: Bruna Costa, et al.
Published: (2020-01-01) -
Modeling the Tumor Microenvironment and Cancer Immunotherapy in Next-Generation Humanized Mice
by: Anna Chen, et al.
Published: (2023-05-01) -
Patient-Derived Tumor Xenograft Models: Toward the Establishment of Precision Cancer Medicine
by: Taichiro Goto
Published: (2020-07-01) -
Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response
by: Feifei Zhang, et al.
Published: (2018-09-01) -
New Therapeutic Perspectives in Prostate Cancer: Patient-Derived Organoids and Patient-Derived Xenograft Models in Precision Medicine
by: Vittoria Rago, et al.
Published: (2023-10-01)